Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-35,000
Closed -$1.68M 55
2019
Q2
$1.68M Hold
35,000
0.39% 39
2019
Q1
$1.4M Sell
35,000
-400
-1% -$14.9K 0.22% 45
2018
Q4
$1.11M Buy
35,400
+1,000
+3% +$33.9K 0.19% 44
2018
Q3
$1.27M Buy
34,400
+1,100
+3% +$44.3K 0.17% 45
2018
Q2
$1.27M Sell
33,300
-10,400
-24% -$405K 0.16% 43
2018
Q1
$2M Hold
43,700
0.23% 39
2017
Q4
$1.83M Sell
43,700
-951,150
-96% -$39.2M 0.16% 47
2017
Q3
$37.1M Buy
+994,850
New +$34.4M 3.11% 9
2016
Q4
Sell
-106,675
Closed -$2.3M 60
2016
Q3
$2.3M Sell
106,675
-136,000
-56% -$2.81M 0.13% 46
2016
Q2
$4.78M Sell
242,675
-4,400
-2% -$86.8K 0.23% 39
2016
Q1
$5.33M Buy
247,075
+47,818
+24% +$935K 0.29% 33
2015
Q4
$4.12M Sell
199,257
-49,992
-20% -$995K 0.23% 45
2015
Q3
$4.49M Buy
249,249
+50,009
+25% +$922K 0.25% 46
2015
Q2
$3.84M Buy
199,240
+3,065
+2% +$61.2K 0.19% 54
2015
Q1
$3.7M Buy
196,175
+79,875
+69% +$1.53M 0.19% 49
2014
Q4
$2.3M Buy
+116,300
New +$2.19M 0.14% 49

Other funds holding TER

M.D. Sass LLC's TER Position: Q3 2019 in Review

M.D. Sass LLC sold out of Teradyne (TER) in Q3 2019, closing a stake of 35,000 shares — an estimated $1.68M sold.

M.D. Sass LLC first reported a position in TER in Q4 2014 and held it in 16 quarters. The position peaked at $37.1M in Q3 2017. 460 funds tracked by Wall St. Rank hold TER as of Q3 2019.

  • M.D. Sass LLC reported no remaining Teradyne position as of Q3 2019 after selling out during the quarter.
  • M.D. Sass LLC sold 35,000 Teradyne shares in Q3 2019, an estimated $1.68M.
  • M.D. Sass LLC first reported a position in Teradyne in Q4 2014 and held it in 16 quarters.
  • M.D. Sass LLC's Teradyne position peaked at $37.1M in Q3 2017.
  • 460 funds tracked by Wall St. Rank held Teradyne as of Q3 2019.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.